跳至主要内容
临床试验/NL-OMON33895
NL-OMON33895已完成不适用

Immune regulation by microRNA implications for diagnosis and treatment of chronic disease development in aging people with rheumatoid arthritis (RA) and osteoarthritis (OA) as disease models. - Immune regulation by microRNA in HC, RA and OA.

niversitair Medisch Centrum Groningen0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • RA patients with comorbidity
  • 1.Fulfilling the ACR classification criteria for RA
  • 2.Age > 65 years
  • 3.No treatment with DMARD (Disease Modifying Antirheumatic Drugs)
  • 4.Presence of co-morbidity;Healthy Controls
  • 1.Have no chronic disease
  • 2.Age > 65 years;RA patients without comorbidity
  • 1.Fulfilling the ACR classification criteria for RA
  • 2.Age > 65 years
  • 3.No treatment with DMARD (Disease Modifying Antirheumatic Drugs)
  • 4.No co-morbidity at start of the study;For OA patients
  • 1.Fulfilling the ACR classification criteria for OA
  • 2.Age >65 years
  • 3.No co-morbidity at start of the study

排除标准

  • For all groups (RA, OA and HC)
  • 1.No informed consent
  • 2.Severe anaemia defined as a Hb of less than 6.0 gr/l

研究者

相似试验